Sigyn Therapeutics (SIGY) Total Debt Growth (3y) (2019 - 2025)
Powered by 
Analysis
Sigyn Therapeutics (SIGY) Total Debt Growth (3y) (2019 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.00 Bn | 175.40 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.82 Bn | 122.60 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.94 Bn | 108.12 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 104.40 Bn | 100.92 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 63.93 Bn | 63.39 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.92 Bn | 45.67 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 20.67 Bn | 20.19 Bn | 684.20 Mn | -10.56% |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | 52.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 52.02% |
| Jun 30, 2025 | 39.57% |
| Mar 31, 2025 | 50.48% |
| Dec 31, 2024 | 82.87% |
| Sep 30, 2024 | 37.78% |
| Jun 30, 2024 | 42.04% |
| Mar 31, 2024 | 62.40% |
| Dec 31, 2023 | 53.93% |
| Sep 30, 2023 | -0.85% |
| Jun 30, 2023 | -4.36% |
| Mar 31, 2023 | -6.21% |
| Dec 31, 2022 | -17.98% |
| Sep 30, 2022 | -20.95% |
| Jun 30, 2022 | -32.08% |
| Mar 31, 2022 | -38.28% |
| Dec 31, 2021 | -39.88% |
| Sep 30, 2021 | -37.56% |
| Jun 30, 2021 | -37.42% |
| Mar 31, 2021 | -37.00% |
| Dec 31, 2020 | -35.72% |